These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 26208600)

  • 41. Distinct expression pattern of microtubule-associated protein/microtubule affinity-regulating kinase 4 in differentiated neurons.
    Moroni RF; De Biasi S; Colapietro P; Larizza L; Beghini A
    Neuroscience; 2006 Nov; 143(1):83-94. PubMed ID: 16973293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The microtubule affinity regulating kinase MARK4 promotes axoneme extension during early ciliogenesis.
    Kuhns S; Schmidt KN; Reymann J; Gilbert DF; Neuner A; Hub B; Carvalho R; Wiedemann P; Zentgraf H; Erfle H; Klingmüller U; Boutros M; Pereira G
    J Cell Biol; 2013 Feb; 200(4):505-22. PubMed ID: 23400999
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of Ser/Pro-rich domain and kinase domain of double cortin-like protein kinase on microtubule-binding activity.
    Nagamine T; Shimomura S; Sueyoshi N; Kameshita I
    J Biochem; 2011 May; 149(5):619-27. PubMed ID: 21278387
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of α-Mangostin as a Potential Inhibitor of Microtubule Affinity Regulating Kinase 4.
    Khan P; Queen A; Mohammad T; Smita ; Khan NS; Hafeez ZB; Hassan MI; Ali S
    J Nat Prod; 2019 Aug; 82(8):2252-2261. PubMed ID: 31343173
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mark4 promotes adipogenesis and triggers apoptosis in 3T3-L1 adipocytes by activating JNK1 and inhibiting p38MAPK pathways.
    Feng M; Tian L; Gan L; Liu Z; Sun C
    Biol Cell; 2014 Sep; 106(9):294-307. PubMed ID: 24989893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of pH on structure, function, and stability of mitochondrial carbonic anhydrase VA.
    Idrees D; Shahbaaz M; Bisetty K; Islam A; Ahmad F; Hassan MI
    J Biomol Struct Dyn; 2017 Feb; 35(2):449-461. PubMed ID: 26828699
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanistic insights into MARK4 inhibition by galantamine toward therapeutic targeting of Alzheimer's disease.
    Adnan M; DasGupta D; Anwar S; Shamsi A; Siddiqui AJ; Snoussi M; Bardakci F; Patel M; Hassan MI
    Front Pharmacol; 2023; 14():1276179. PubMed ID: 37795023
    [No Abstract]   [Full Text] [Related]  

  • 48. PASK (proline-alanine-rich Ste20-related kinase) binds to tubulin and microtubules and is involved in microtubule stabilization.
    Tsutsumi T; Kosaka T; Ushiro H; Kimura K; Honda T; Kayahara T; Mizoguchi A
    Arch Biochem Biophys; 2008 Sep; 477(2):267-78. PubMed ID: 18675246
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A cell-penetrating peptide derived from SARS-CoV-2 protein Orf9b allosterically inhibits MARK4 activity and mitigates tau toxicity.
    Oba T; Homma D; Limlingan SJM; Fukuchi A; Asada A; Saito T; Ando K
    Neurobiol Dis; 2023 Nov; 188():106334. PubMed ID: 37884211
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mark4 promotes oxidative stress and inflammation via binding to PPARγ and activating NF-κB pathway in mice adipocytes.
    Liu Z; Gan L; Chen Y; Luo D; Zhang Z; Cao W; Zhou Z; Lin X; Sun C
    Sci Rep; 2016 Feb; 6():21382. PubMed ID: 26888669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential signature of the centrosomal MARK4 isoforms in glioma.
    Magnani I; Novielli C; Fontana L; Tabano S; Rovina D; Moroni RF; Bauer D; Mazzoleni S; Colombo EA; Tedeschi G; Monti L; Porta G; Bosari S; Frassoni C; Galli R; Bello L; Larizza L
    Anal Cell Pathol (Amst); 2011; 34(6):319-38. PubMed ID: 22156016
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemical genetic approach identifies microtubule affinity-regulating kinase 1 as a leucine-rich repeat kinase 2 substrate.
    Krumova P; Reyniers L; Meyer M; Lobbestael E; Stauffer D; Gerrits B; Muller L; Hoving S; Kaupmann K; Voshol J; Fabbro D; Bauer A; Rovelli G; Taymans JM; Bouwmeester T; Baekelandt V
    FASEB J; 2015 Jul; 29(7):2980-92. PubMed ID: 25854701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of MARK4 by serotonin as an attractive therapeutic approach to combat Alzheimer's disease and neuroinflammation.
    Shamsi A; DasGupta D; Alhumaydhi FA; Khan MS; Alsagaby SA; Al Abdulmonem W; Hassan MI; Yadav DK
    RSC Med Chem; 2022 Jun; 13(6):737-745. PubMed ID: 35814926
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of pH on the structure and function of pyruvate dehydrogenase kinase 3: Combined spectroscopic and MD simulation studies.
    Anwar S; Kar RK; Haque MA; Dahiya R; Gupta P; Islam A; Ahmad F; Hassan MI
    Int J Biol Macromol; 2020 Mar; 147():768-777. PubMed ID: 31982536
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Design and Development of Small-Molecule Arylaldoxime/5-Nitroimidazole Hybrids as Potent Inhibitors of MARK4: A Promising Approach for Target-Based Cancer Therapy.
    Peerzada MN; Khan P; Khan NS; Avecilla F; Siddiqui SM; Hassan MI; Azam A
    ACS Omega; 2020 Sep; 5(36):22759-22771. PubMed ID: 32954123
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conformational instability of the MARK3 UBA domain compromises ubiquitin recognition and promotes interaction with the adjacent kinase domain.
    Murphy JM; Korzhnev DM; Ceccarelli DF; Briant DJ; Zarrine-Afsar A; Sicheri F; Kay LE; Pawson T
    Proc Natl Acad Sci U S A; 2007 Sep; 104(36):14336-41. PubMed ID: 17726107
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Linagliptin and Empagliflozin Inhibit Microtubule Affinity Regulatory Kinase 4: Repurposing Anti-Diabetic Drugs in Neurodegenerative Disorders Using In Silico and In Vitro Approaches.
    Atiya A; Das Gupta D; Alsayari A; Alrouji M; Alotaibi A; Sharaf SE; Abdulmonem WA; Alorfi NM; Abdullah KM; Shamsi A
    ACS Omega; 2023 Feb; 8(7):6423-6430. PubMed ID: 36844587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. More stable structure of wheat germ lipase at low pH than its native state.
    Ahmad E; Fatima S; Khan MM; Khan RH
    Biochimie; 2010 Jul; 92(7):885-93. PubMed ID: 20363283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vanillin-Isatin Hybrid-Induced MARK4 Inhibition As a Promising Therapeutic Strategy against Hepatocellular Carcinoma.
    Ahmed S; Queen A; Irfan I; Siddiqui MN; Abdulhameed Almuqdadi HT; Setia N; Ansari J; Hussain A; Hassan MI; Abid M
    ACS Omega; 2024 Jun; 9(24):25945-25959. PubMed ID: 38911744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Design and development of Isatin-triazole hydrazones as potential inhibitors of microtubule affinity-regulating kinase 4 for the therapeutic management of cell proliferation and metastasis.
    Aneja B; Khan NS; Khan P; Queen A; Hussain A; Rehman MT; Alajmi MF; El-Seedi HR; Ali S; Hassan MI; Abid M
    Eur J Med Chem; 2019 Feb; 163():840-852. PubMed ID: 30579124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.